Table 2.

Effect of Antiretroviral Agents on LTB4Synthesis in PBM and PMN Treated With and Without GM-CSF In Vitro

LTB4pg/106 Cells % Control
AZT 3TC IndinavirCombination
PBM  90.0 ± 11.9  103.1 ± 20.5 125.7 ± 20.8  129.6 ± 30.7  
PBM + GM-CSF 94.8 ± 10.2  100.4 ± 9.3  140.6 ± 27.9 86.6 ± 6.4  
PMN  114.5 ± 4.2  113.7 ± 3.4 118.6 ± 5.7  112.9 ± 3.6  
PMN + GM-CSF 109.3 ± 5.6  105.4 ± 2.2  113.6 ± 14.8 123.2 ± 5.3 
LTB4pg/106 Cells % Control
AZT 3TC IndinavirCombination
PBM  90.0 ± 11.9  103.1 ± 20.5 125.7 ± 20.8  129.6 ± 30.7  
PBM + GM-CSF 94.8 ± 10.2  100.4 ± 9.3  140.6 ± 27.9 86.6 ± 6.4  
PMN  114.5 ± 4.2  113.7 ± 3.4 118.6 ± 5.7  112.9 ± 3.6  
PMN + GM-CSF 109.3 ± 5.6  105.4 ± 2.2  113.6 ± 14.8 123.2 ± 5.3 

PBM and PMN were harvested from healthy controls, and incubated as described in Materials and Methods. The cells were incubated overnight with AZT (Retrovir) 0.63 μg/mL, Indinavir (Crixivan) 8.9 μg/mL, and 3TC (Epivir) 1.5 μg/mL singly and in combination. Cells were also incubated with and without GM-CSF (250 U/mL) overnight. LTB4 synthesis was determined by EIA after stimulation of PBM and PMN with A23187 (10 μmol/L) plus exogenous AA (50 μmol/L), and A23187 (10 μmol/L), respectively, for 30 minutes. Data are from a representative experiment performed in triplicate: control PBM LTB4 levels were 5,796.8 ± 1,678 pg/106cells; PBM + GM-CSF 5,544 ± 978 pg/106 cells; PMN 9,608.0 ± 2,072 pg/106 cells; PMN + GM-CSF 27,429 ± 236.4 pg/106 cells. P = not significant (NS) compared with cells not treated with antiretroviral agents.

Close Modal

or Create an Account

Close Modal
Close Modal